0001209191-22-014133.txt : 20220301 0001209191-22-014133.hdr.sgml : 20220301 20220301170852 ACCESSION NUMBER: 0001209191-22-014133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220227 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOYER ANDREW S CENTRAL INDEX KEY: 0001239546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 22699532 MAIL ADDRESS: STREET 1: C/O WATSON PHARMA INC STREET 2: 360 MOUNT KEMBLE AVE CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-27 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001239546 BOYER ANDREW S C/O AMNEAL PHARMACEUTICALS, INC. BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President Class A Common Stock 2022-02-27 4 M 0 31662 A 182924 D Class A Common Stock 2022-02-27 4 F 0 16434 4.59 D 166490 D Restricted Stock Units 2022-02-27 4 M 0 31662 0.00 D Class A Common Stock 31662 63325 D Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. On February 27, 2020, the reporting person was granted 126,649 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. /s/ Meredith Cook, Attorney-in-fact 2022-03-01